NCT06757257招募中不适用
Special Drug Use-results Survey for Long-term Use (Fostamatinib)
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 149
- 试验地点
- 1
- 主要终点
- Adverse events
研究概览
简要总结
The purpose of this survey is evaluating the safety and efficacy of long-term administration of fostamatinib for Japanese patients with chronic idiopathic thrombocytopenic purpura under actual conditions of use.
详细描述
The purpose of this survey is evaluating the safety and efficacy of long-term administration of fostamatinib for Japanese patients with chronic idiopathic thrombocytopenic purpura under actual conditions of use.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with chronic idiopathic thrombocytopenic purpura who are treatment with fostamatinib for the first time.
排除标准
- 未提供
研究组 & 干预措施
fostamatinib treatmented
干预措施: fostamatinib (Drug)
结局指标
主要结局
Adverse events
时间窗: 18 months
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
招募中
不适用
Special Drug Use-results Survey for Long-term Use（Avacopan）Microscopic Polyangiitis (MPA)Granulomatosis With Polyangiitis (GPA)NCT06758271Kissei Pharmaceutical Co., Ltd.250
已完成
不适用
Special Drug Use-results Survey for long-term use of Doxil injection 20mg (ovarian cancer aggravated after chemotherapy)ovarian cancer aggravated after chemotherapyJPRN-UMIN000015902Janssen Pharmaceutical K.K.500
已完成
不适用
Special Drug Use-Results Survey for Long-term Use of XEPLION TRI Aqueous Suspension for IM Injection 175 mg, 263 mg, 350 mg, and 525 mg SyringeSchizophreniaJPRN-UMIN000042033Janssen Pharma990
已完成
不适用
A Long Term Safety and Efficacy Study of Fabrazyme Replacement Therapy in Japanese Patients With Fabry Disease.Fabry DiseaseNCT00233870Genzyme, a Sanofi Company405
已完成
不适用
Special Drug Use Investigation for ADOAIR (Fluticasone/Salmeterol)Respiratory DisordersNCT01395862GlaxoSmithKline1,001